MedTrace Logo

Differences Between Women With COVID-19 and Long Covid

NCT05669235 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2023-10-16

No results posted yet for this study

Summary

The coronavirus disease of 2019 (COVID-19) has infected more than 630 million people and resulted in more than 6.5 million deaths worldwide. Among the possible sequelae of the virus, a disorder called long COVID has shown to affect about 10% of those infected, mostly adult women, without comorbidities.

Long COVID corresponds to a multisystemic syndrome following the acute period of the disease, in which the person maintains persistent symptoms such as fatigue, dyspnea, cough, memory loss, muscle and joint pain, among others.

Now that time has passed, it is necessary to verify why there are women who present symptoms of long covid and others do not.

Conditions

Interventions

DIAGNOSTIC_TEST

Questionnaires

A series of questionnaires will be carried out that assess both respiratory problems, depression and strength.

Sponsors & Collaborators

  • University of Valencia

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-29
Primary Completion
2023-02-28
Completion
2023-10-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05669235 on ClinicalTrials.gov